[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100495881":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":28,"centralContacts":35,"locations":41,"responsibleParty":247,"collaborators":28,"id":251,"slug":252,"hasResults":253,"nctId":254,"briefTitle":255,"officialTitle":256,"acronym":257,"eligibilityCriteria":258,"healthyVolunteers":253,"sex":259,"minAge":260,"maxAge":28,"enrollmentInfo":261,"targetDuration":28,"studyType":264,"phases":265,"briefSummary":267,"conditions":268,"keywords":270,"overallStatus":155,"whyStopped":28,"lastUpdateSubmitDate":275,"lastUpdatePostDateStruct":276,"startDateStruct":279,"completionDateStruct":281,"leadSponsor":283,"locationsCount":284},{"fullName":5,"class":6},"Shanghai Tong Ren Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"SAV arm","EXPERIMENTAL","Untreated acute myeloid leukemia who are ineligible for intensive chemotherapy or who refuse to receive intensive chemotherapy will receive selinexor in combination with azacitidine and venetoclax, 28 days per cycle, patients can receive transplants at any time once they achieved complete remission and other patients will continue to receive SAV regimen until disease progression or unacceptable toxic effects.",[13,14,15],"Drug: Selinexor","Drug: Azacitidine","Drug: Venetoclax",[17,24,29],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":22},"DRUG","Selinexor","Selinexor 60mg, PO d3,10,17",[9],[23],"xpo1 inhibitor",{"type":18,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"Azacitidine","Azacitidine 75mg\u002Fm2, IV d1-3, 8-9, 15-16",[9],null,{"type":18,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"Venetoclax","Venetoclax 100mg PO on day 1 and 200mg on day 2, 400mg on day 3-14",[9],[34],"ABT199",[36],{"name":37,"role":38,"phone":39,"phoneExt":28,"email":40},"Ligen Liu, MD","CONTACT","18017337037","llg3532@shtrhospital.com",[42,57,68,79,90,101,112,123,131,142,153,162,173,184,192,203,214,225,236],{"facility":43,"status":44,"city":45,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Changzhou Municipal No.1 People's Hospital","NOT_YET_RECRUITING","Changzhou","China","CN",{"type":49,"coordinates":50},"Point",[51,52],119.95401,31.77359,{"lat":52,"lon":51},[55],{"name":56,"role":38,"phone":28,"phoneExt":28,"email":28},"weiying gu",{"facility":58,"status":44,"city":59,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":60,"geoPoint":64,"contacts":65},"Sichuan Provincial People's Hospital","Chengdu",{"type":49,"coordinates":61},[62,63],104.06667,30.66667,{"lat":63,"lon":62},[66],{"name":67,"role":38,"phone":28,"phoneExt":28,"email":28},"hui li",{"facility":69,"status":44,"city":70,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":71,"geoPoint":75,"contacts":76},"Jilin University China Japan Union Hospital","Ch’ang-ch’un",{"type":49,"coordinates":72},[73,74],126.24667,42.74694,{"lat":74,"lon":73},[77],{"name":78,"role":38,"phone":28,"phoneExt":28,"email":28},"yuansong bai",{"facility":80,"status":44,"city":81,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"Harbin Institute of Hematology and Oncology","Ha’erbin",{"type":49,"coordinates":83},[84,85],101.742,31.8696,{"lat":85,"lon":84},[88],{"name":89,"role":38,"phone":28,"phoneExt":28,"email":28},"hong liang",{"facility":91,"status":44,"city":92,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":93,"geoPoint":97,"contacts":98},"Anhui Provincial Hospital","Hefei",{"type":49,"coordinates":94},[95,96],117.28083,31.86389,{"lat":96,"lon":95},[99],{"name":100,"role":38,"phone":28,"phoneExt":28,"email":28},"xiaoyu zhu",{"facility":102,"status":44,"city":103,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"the first hospital of Jiaxing affiliated hospital of Jiaxing University","Jiaxing",{"type":49,"coordinates":105},[106,107],120.75,30.7522,{"lat":107,"lon":106},[110],{"name":111,"role":38,"phone":28,"phoneExt":28,"email":28},"hui zeng",{"facility":113,"status":44,"city":114,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":115,"geoPoint":119,"contacts":120},"Gansu Provincial People's Hospital","Lanzhou",{"type":49,"coordinates":116},[117,118],103.83987,36.05701,{"lat":118,"lon":117},[121],{"name":122,"role":38,"phone":28,"phoneExt":28,"email":28},"qike zhang",{"facility":124,"status":44,"city":114,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":125,"geoPoint":127,"contacts":128},"Lanzhou University NO.2 Hospital",{"type":49,"coordinates":126},[117,118],{"lat":118,"lon":117},[129],{"name":130,"role":38,"phone":28,"phoneExt":28,"email":28},"pengyun zeng",{"facility":132,"status":44,"city":133,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":134,"geoPoint":138,"contacts":139},"Ningbo Medical Center Lihuili Huspital","Ningbo",{"type":49,"coordinates":135},[136,137],121.54945,29.87819,{"lat":137,"lon":136},[140],{"name":141,"role":38,"phone":28,"phoneExt":28,"email":28},"jing le",{"facility":143,"status":44,"city":144,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":145,"geoPoint":149,"contacts":150},"Shanghai Ruijin Hospital","Shanghai",{"type":49,"coordinates":146},[147,148],121.45806,31.22222,{"lat":148,"lon":147},[151],{"name":152,"role":38,"phone":28,"phoneExt":28,"email":28},"Junmin Li",{"facility":154,"status":155,"city":144,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":156,"geoPoint":158,"contacts":159},"Shanghai Tong Ren hospital","RECRUITING",{"type":49,"coordinates":157},[147,148],{"lat":148,"lon":147},[160],{"name":161,"role":38,"phone":39,"phoneExt":28,"email":40},"Ligen Liu",{"facility":163,"status":44,"city":164,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":165,"geoPoint":169,"contacts":170},"The First Hospital of China Medical University","Shenyang",{"type":49,"coordinates":166},[167,168],123.43278,41.79222,{"lat":168,"lon":167},[171],{"name":172,"role":38,"phone":28,"phoneExt":28,"email":28},"xiaojing yan",{"facility":174,"status":44,"city":175,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":176,"geoPoint":180,"contacts":181},"The First Hospital of Hebei Medical University","Shijia Zhuang",{"type":49,"coordinates":177},[178,179],109.84894,34.17775,{"lat":179,"lon":178},[182],{"name":183,"role":38,"phone":28,"phoneExt":28,"email":28},"qingchi liu",{"facility":185,"status":44,"city":175,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":186,"geoPoint":188,"contacts":189},"The Second Hospital of Hebei Medical University",{"type":49,"coordinates":187},[178,179],{"lat":179,"lon":178},[190],{"name":191,"role":38,"phone":28,"phoneExt":28,"email":28},"jinhai ren",{"facility":193,"status":44,"city":194,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":195,"geoPoint":199,"contacts":200},"First Affiliated Hospital of Xinjiang Medical University","Ürümqi",{"type":49,"coordinates":196},[197,198],87.60046,43.80096,{"lat":198,"lon":197},[201],{"name":202,"role":38,"phone":28,"phoneExt":28,"email":28},"ming jiang",{"facility":204,"status":44,"city":205,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":206,"geoPoint":210,"contacts":211},"the Second Affiliated Hospital of Wannan Medical College","Wuhu",{"type":49,"coordinates":207},[208,209],118.42947,31.35259,{"lat":209,"lon":208},[212],{"name":213,"role":38,"phone":28,"phoneExt":28,"email":28},"dongping huang",{"facility":215,"status":44,"city":216,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":217,"geoPoint":221,"contacts":222},"Xi'an International Medical Center","Xi'an",{"type":49,"coordinates":218},[219,220],108.92861,34.25833,{"lat":220,"lon":219},[223],{"name":224,"role":38,"phone":28,"phoneExt":28,"email":28},"yingmin liang",{"facility":226,"status":44,"city":227,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":228,"geoPoint":232,"contacts":233},"Northern Jiangsu People's Hospital","Yangzhou",{"type":49,"coordinates":229},[230,231],119.43583,32.39722,{"lat":231,"lon":230},[234],{"name":235,"role":38,"phone":28,"phoneExt":28,"email":28},"mei su",{"facility":237,"status":44,"city":238,"state":28,"zip":28,"country":46,"countryCode":47,"cosmosGeoPoint":239,"geoPoint":243,"contacts":244},"Yixing People's Hospital","Yixing",{"type":49,"coordinates":240},[241,242],119.82016,31.36059,{"lat":242,"lon":241},[245],{"name":246,"role":38,"phone":28,"phoneExt":28,"email":28},"wenzhong wu",{"type":248,"investigatorFullName":249,"investigatorTitle":250,"investigatorAffiliation":5,"oldNameTitle":28,"oldOrganization":28},"PRINCIPAL_INVESTIGATOR","Liu Ligen","Director","100495881","phase-2-a-study-of-selinexor-in-combination-with-azacitidine-and-venetoclax-sav-regimen-in-treatment-nave-participants-with-acute-myeloid-leukemia-100495881",false,"NCT05736965","A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia","Clinical Efficacy and Safety of Selinexol Combined With Azacitidine and Venetoclax (SAV Regimen) in the Treatment of Acute Myeloid Leukemia (AML)-a Multi-center, Single-arm, Prospective Clinical Study","SAV","Inclusion Criteria:\n\n* Known and written informed consent voluntarily\n* Age ≥ 18 years\n* Newly diagnosed AML patients (per WHO 2022 classification criteria for AML diagnosis), who are not suitable for intensive chemotherapy:\n\n  * ≥75 years or\n  * Aged 18 to 74 years with at least one of the following comorbidities: Eastern Cooperative Oncology Group (ECOG) performance status score of 2 or 3 or 4; Cardiac history of Congestive Heart Failure (CHF) requiring treatment or Ejection Fraction \\\u003C= 50% or chronic stable angina; Diffusing capacity of the Lung for Carbon Monoxide (DLCO) \\\u003C= 65% or Forced Expiratory Volume in 1 second (FEV1) \\\u003C= 65%; Creatinine clearance \\>= 30 mL\u002Fmin to \\\u003C 45 ml\u002Fmin; Moderate hepatic impairment with total bilirubin \\> 1.5 to \\\u003C= 3.0 × Upper Limit of Normal (ULN); Any other comorbidity that the physician judges to be incompatible with intensive chemotherapy .\n* patients who are suitable for intensive chemotherapy but refuse it\n* Liver function meets the following criteria:\n\naspartate aminotransferase (AST) ≤ 3.0×ULN\\*; alanine aminotransferase (ALT) ≤ 3.0×ULN\\*; Bilirubin≤1.5×ULN\\*; For subjects \\\u003C75 years old, the bilirubin level can be ≤3.0×ULN;\n\n* Unless due to leukemic organ involvement.\n\n  * Renal function meets the following criteria: creatinine clearance ≥ 30 mL\u002Fmin (Cockroft-Gault formula)\n  * Life expectancy ≥ 4 weeks\n\nExclusion Criteria:\n\n* History of any malignancies prior to study entry with exception noted in the protocol.\n* Participant has known HIV infection, active hepatitis B virus (HBV) and\u002For hepatitis C virus (HCV) .\n* Participant has known active central nervous system (CNS) involvement with AML.\n* Must not have received prior anti-AML treatment except for hydroxyurea","ALL","18 Years",{"count":262,"type":263},58,"ESTIMATED","INTERVENTIONAL",[266],"PHASE2","This is a prospective, single-arm, multi-center clinical trial to evaluate the efficacy and safety of selinexor in combination with azacitidine and venetoclax for untreated acute myeloid leukemia.",[269],"AML, Adult",[271,272,273,274],"selinexor","untreated AML","azacitidine","venetoclax","2023-03-13",{"date":277,"type":278},"2023-03-15","ACTUAL",{"date":280,"type":278},"2023-02-20",{"date":282,"type":263},"2027-04-30",{"name":5,"class":6},19]